Leibniz Institute for Immunotherapy (LIT)
Time frame: 1 December 2022 - 30 November 2023Article ‘Count’ and ‘Share’ for Leibniz Institute for Immunotherapy (LIT) based on listed parameters only.
The articles listed below published by authors from Leibniz Institute for Immunotherapy (LIT), organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
Immunity |
1 | 0.01 |
Molecular Cell |
1 | 0.30 |
The EMBO Journal |
1 | 0.03 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.